Concepedia

Paola Kučan Brlić

PK

5

Publications

218

Citations

5

H-Index

2016

Active since

Affiliations

University of Rijeka(Current)

Hebrew University of Jerusalem

Medizinische Hochschule Hannover

Paola Kučan Brlić is an author at University of Rijeka specializing in vaccination, virology, and vaccine development.

ORCID

Top concepts

Publications per year

2016–2022

5

Publications

5

Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

Adi Reches, Yael Ophir, Natan Stein et al. · Journal for ImmunoTherapy of Cancer · 2020 · 118 citations · Full text

Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection

T. Rovis, Paola Kučan Brlić, Noa Kaynan et al. · The Journal of Experimental Medicine · 2016 · 56 citations · Full text

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern

Abigael Chaouat, Ilija Brizić, Paola Kučan Brlić et al. · iScience · 2022 · 18 citations · Full text

Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion

Ivana Strazic Geljic, Paola Kučan Brlić, Guillem Angulo et al. · eLife · 2020 · 14 citations · Full text

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study

Paola Kučan Brlić, Martina Pavletić, Mate Lerga et al. · Viruses · 2022 · 12 citations · Full text

, , +13

Rows per page

1–5 of 5